Description
Thienylbutyl isothiocyanate (ITC) exhibits chemopreventive activity, inhibiting the development of carcinogenesis.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Thienylbutyl isothiocyanate (ITC) exhibits chemopreventive activity, inhibiting the development of carcinogenesis.
| Cas No. | 288323-36-4 |
|---|---|
| Purity | ≥96% |
| Formula | C9H11NS2 |
| Formula Wt. | 197.32 |
| Chemical Name | 2-(4-isothiocyanatobutyl)thiophene |
| IUPAC Name | 2-(4-isothiocyanatobutyl)thiophene |
| Appearance | Clear Liquid |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lam LKT, Kenney P, Bergstrom CP, et al. Chem Biol Interact. 1999;127:163-80.
Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199.
Peptide, vasopressin analog; V1/2 agonist.
Analog of glutamate
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Non-essential amino acid found in Camellia and ...
SERT inhibitor.
Imidazole; 14-α demethylase inhibitor, potenti...
ACE inhibitor.
TLR4 inhibitor.
Furan derivative.
α2-adrenergic and imidazoline-1 antagonist, AT...
Synthesis impurity
Fibrate; PPARα agonist.
Staurosporine analog; PKC inhibitor.
Smo inhibitor.
Morpholine derivative.
STING agonist
FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.<...
Induces ER degradation.
Synthetic glucocorticoid
L-type Ca2+ channel blocker.